Health & Fitness

According to FutureWise analysis the market for molecular grade plates in 2026 is US$ 0.35 billion, and is expected to reach US$ 0.47 billion by 2036 at a CAGR of 2.99%. The steady growth is driven by rising use of molecular grade plates in genomics, proteomics, and high-throughput screening. Increasing research in pharmaceutical and biotechnology labs, along with the demand for contamination-free, high-precision consumables, continues to boost adoption. The adoption of molecular grade plates is essential in various procedures, including qualitative and quantitative Real Time PCR, nucleic acid purification, and DNA sequencing. These plates are specifically designed for frequent use in applications such as sample storage and high-throughput processing. As the global prevalence of chronic diseases, such as cancer, viral infections, and heart and circulatory issues, continues to rise, the demand for diagnostic tools like the Polymerase Chain Reaction (PCR) is also increasing. PCR is ... Continue reading →

According to FutureWise analysis the market for molecular imaging in 2026 is US$ 8.20 billion, and is expected to reach US$ 13.53 billion by 2036 at a CAGR of 5.14%. The growth is fueled by the rising adoption of advanced imaging modalities like PET, SPECT, and hybrid systems for early disease detection and therapy monitoring. Increasing applications in oncology, cardiology, and neurology, along with technological advancements and investments in precision medicine, are driving market expansion. Molecular imaging represents a sophisticated approach in medical imaging, allowing for the visualization, characterization, and measurement of biological processes at the molecular and cellular levels within living organisms. Unlike traditional imaging methods that mainly focus on anatomical structures, molecular imaging emphasizes functional and biochemical changes. This unique focus enables healthcare professionals and researchers to identify diseases at their earliest stages—often even ... Continue reading →

According to FutureWise analysis, the Molecular Weight Marker Market in 2026 is US$0.93 billion, and is expected to reach US$1.72 billion by 2036 at a CAGR of 6.34%.   Molecular weight markers are essential tools used to determine the size of proteins, DNA, or RNA. The migration distance of these markers during electrophoresis is influenced by their molecular weight. Both polyacrylamide gels and agarose gels can be utilized to analyze these markers. Before starting the electrophoresis process, molecular weight markers are positioned next to the sample lane, allowing researchers to ascertain the size and weight of unknown molecules. These markers serve multiple purposes, including studying genomes, genes, and related diseases. Typically referred to as protein standards or ladders, molecular weight markers help estimate protein molecular weights and track the progress of electrophoretic separation or transfer. They are also used as positive controls to validate analysis ... Continue reading →

According to FutureWise analysis the market for Molecular Microbiology in 2026 is US$ 10.05 billion, and is expected to reach US$ 22.17 billion by 2036 at a CAGR of 8.23%. Strong growth is fueled by the increasing demand for rapid and accurate pathogen detection in clinical diagnostics, food safety, and environmental testing. Advancements in PCR, sequencing technologies, and automated platforms, along with a focus on antimicrobial resistance, are driving market expansion. Molecular microbiology is a specialized area within microbiology that delves into the intricacies of microorganisms at the molecular level. It investigates their genetic structures, cellular functions, and interactions with both their environments and host organisms. By employing various molecular biology techniques, this field grants profound insights into the biology of bacteria, viruses, fungi, and parasites, exploring how they operate, evolve, and contribute to diseases. This discipline has become fundamental to ... Continue reading →

According to FutureWise analysis, the Molybdenum-99 market in 2026 is US$ 4.98 billion, and is expected to reach US$7.35 billion by 2036 at a CAGR of 3.97%.  The Molybdenum-99 market is mainly driven by its essential role as the parent isotope for Technetium-99m, the most commonly used medical radioisotope in nuclear medicine procedures. The rising incidence of cardiovascular diseases and cancer around the world is increasing the demand for diagnostic imaging techniques that depend on Mo-99/Tc-99m generators. Challenges in the supply chain and the aging infrastructure of the nuclear reactors that produce Mo-99 have led to significant investments in alternative production methods, such as neutron capture and linear accelerator technologies. North America and Europe hold a substantial share of the market due to high utilization rates of nuclear medicine procedures and their well-established healthcare systems. However, the market faces ongoing concerns regarding supply ... Continue reading →

According to FutureWise analysis the market for monoclonal antibody diagnostic reagents in 2026 is US$ 10.36 billion, and is expected to reach US$ 29.15 billion by 2036 at a CAGR of 10.90%. Rapid growth is fueled by rising demand for specific diagnostic tools in oncology, infectious diseases, and autoimmune disorders. Advancements in antibody engineering, greater adoption of immunoassays, and increased use in clinical and research settings are also driving market expansion. Monoclonal antibody diagnostic reagents are specialized biological tools integral to medical diagnostics. They are utilized to detect, identify, and quantify specific target molecules, including proteins, hormones, and pathogens. These reagents are derived from a single clone of immune cells, which ensures their uniformity and precise binding to designated antigens. As a result of their high specificity and consistency, monoclonal antibodies have become essential components in contemporary diagnostic assays, ... Continue reading →

According to FutureWise analysis, the monoclonal antibodies market in 2026 is US$269.41 billion and is expected to reach US$701.10 billion by 2036 at a CAGR of 10.04%.  The monoclonal antibodies market is experiencing significant growth due to their increasing applications in oncology, autoimmune diseases, and the treatment of infectious diseases. Technological advancements in antibody engineering, such as bispecific antibodies and antibody-drug conjugates, are creating new therapeutic options and improving treatment effectiveness. The oncology segment represents the largest portion of this market, as monoclonal antibodies are essential therapies for various cancers, including breast cancer, lung cancer, and hematological malignancies. The rising adoption of biosimilars is making monoclonal antibody therapies more accessible and affordable, especially in emerging markets where healthcare costs are a significant concern. Currently, North America leads the market, ... Continue reading →

According to FutureWise analysis, the Monocyte Activation Tests market in 2026 is US$0.64 billion, and is expected to reach US$1.82 billion by 2036 at a CAGR of 10.71%.   The Monocyte Activation Tests market is driven by the growing adoption of these assays as alternatives to traditional rabbit pyrogen tests for detecting endotoxins and non-endotoxin pyrogens in pharmaceutical products and medical devices. Regulatory support from agencies including the FDA and European Pharmacopoeia for replacing animal-based testing methods is accelerating market growth and encouraging pharmaceutical manufacturers to transition to MAT-based approaches. The biopharmaceutical industry represents the largest end-user segment, utilizing monocyte activation tests for quality control of parenteral drugs, vaccines, and biologics to ensure patient safety. Technological advancements in test sensitivity and specificity, along with the development of standardized MAT kits, are improving ... Continue reading →

According to FutureWise analysis, the mononucleosis diagnostic market is expected to register a CAGR of 5.02% from 2026-2036.  The mononucleosis diagnostic market is being propelled by greater awareness of Epstein-Barr virus infections and the rising incidence of infectious mononucleosis among adolescents and young adults worldwide. Technological advancements in rapid diagnostic testing, such as point-of-care immunoassays and molecular diagnostic methods, are enhancing diagnostic accuracy and shortening the turnaround time for test results. The transition from traditional heterophile antibody tests to more specific EBV-targeted serological assays is improving clinical decision-making and decreasing the occurrence of false-negative results, especially in pediatric populations.North America captures a significant share of the market, driven by high disease awareness, a well-established healthcare infrastructure, and widespread access to diagnostic testing facilities. Additionally, ... Continue reading →

It sometimes becomes problematic to bring the corpse of a dead relative to the cremation ground, as the necessary steps involved in arranging the transportation of the dead body are tough. In such cases, choosing an appropriate solution would be highly beneficial, and Panchmukhi Mortuary Box Transportation in Bangalore has been designed to complete the process of corpse transportation without any difficulties. We aim to be the best support system for the families associated with the dead and ensure the entire shifting is done right on time. With our dedicated staff and advanced features, we manage to present services that are completely favorable to the urgent requirements of the people, ensuring the involvement of the highest level of efficiency while putting forth a solution in correlation to your needs. Our mortuary ambulances, heresy vans, and Dead Body Transportation Services in Bangalore are ready to take corpses to the selected destination without intending to cause any ... Continue reading →